Oncolytics Biotech and PrECOG collaborate to study metastatic breast cancer

[News]

Oncolytics Biotech Inc. , currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, and PrECOG LLC, a leading cancer research network, today announced their collaboration in which PrECOG will run the BRACELET-1 (PrE0113) study.

More... (https://www.news-medical.net/news/20191022/Oncolytics-Biotech-and-PrECOG-collaborate-to-study-metastatic-breast-cancer.aspx)